Immunomedics Inc.

Immunomedics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
186.83 M
Public Float
125.77 M
Immunomedics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2
Market Cap
$2.71 B
Shares Outstanding
191.54 M
Public Float
170.74 M

Profile

Address
300 The American Road
Morris Plains New Jersey 07950
United States
Employees -
Website http://www.immunomedics.com
Updated 07/08/2019
Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments.

Financials

View All

William Fricker
Executive Director & Principal Accounting Officer
Behzad Aghazadeh
Chairman